Navigation Links
Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
Date:4/27/2008

TAMPA, Fla., April 27 /PRNewswire-FirstCall/ -- Calvin A. Grant, MD, Retina Macular Care, presented the results from his 60-patient retrospective case control study that was designed to evaluate the adjuvant use of Xibrom(TM) (bromfenac 0.09mg ophthalmic solution) in Lucentis(R) (ranibizumab) treatment of choroidal neovascularization secondary to age-related macular degeneration (AMD) in an oral poster presentation at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). Dr. Grant reported patients who received Xibrom in addition to Lucentis (the Combination Group) required 1.6 +/- 0.69 injections of Lucentis during the six-month study period, while patients who received Lucentis only received 4.5 +/- 0.41 injections (p=0.0002). The original abstract, which was published in February 2008, stated there was a numerical trend in favor of the Combination Group on improvement in visual acuity but this difference did not achieve statistical significance. However, upon rigorous review and further statistical analysis, the data has shown the Combination Group did show a statistically significant improvement in visual acuity. In the Combination Group, mean visual acuity increased 1.2 +/- 1.64 lines compared with 0.06 +/-0.66 lines in patients in the Lucentis-only group (p=0.001).

The study results were gathered from 60 patients receiving Lucentis therapy for wet AMD. Patients were monitored monthly using optical coherence tomography (OCT) and fluorescein angiography. When subretinal fluid from leaking vessels was detected by OCT, patients were re-injected with Lucentis. 30 patients received Xibrom dosed twice daily in addition to the Lucentis injection (the Combination Group), and their results were compared to 30 patients who received Lucentis only. There were no adverse events associated with the extended topical administration of bromfenac.

ISTA Pharmaceuticals (Nasdaq:

SOURCE ISTA Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
3. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
4. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
5. Chinese SFDA Grants Immtech Fast Track Status
6. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
7. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
8. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
9. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
10. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
11. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 20, 2014 Oxis International, Inc. ... , the election of Anthony J. Cataldo as ... Effective November 19, 2014, Ken Eaton ... the Board of Directors of Oxis International, Inc. to pursue ... has been named Chief Executive Officer of Oxis International, Inc. ...
(Date:11/21/2014)... 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... offering of $80,000,000 aggregate principal amount of 5.25% Convertible ... private offering within the United States ... buyers pursuant to Rule 144A under the Securities Act ... also granted the initial purchasers an option to purchase ...
(Date:11/18/2014)... ANGELES , Nov. 18, 2014  Sanguine ... development, patient engagement and study recruitment – will ... called Sangre, to help Pfizer Inc. find and ... (CIP) and their family members to participate in ... potentially identify DNA mutations and hopefully aid in ...
Breaking Medicine Technology:OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2
... , KNOXVILLE, Tenn., Dec. 2 ... nation,s largest provider of hospital-based clinical outsourcing, announced it ... two groups in South Carolina and Illinois. , An ... S.C., will allow TeamHealth Teleradiology to provide services for ...
... , WALTHAM, Mass. and NEW YORK, Dec. ... and NYU Langone Medical Center announced findings from a study ... osteoarthritis have been published this week in the "Online First" ... at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf . Results from ...
Cached Medicine Technology:TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4
(Date:11/22/2014)... New York (PRWEB) November 22, 2014 ... on behalf of patients who allegedly developed Type 2 ... in the federal multidistrict litigation now underway in U.S. ... reports. According to court documents, the litigation will convene ... a.m. The Court has directed Lead Counsel for Plaintiffs ...
(Date:11/22/2014)... UWDress.com is gratified to introduce its new collection of ... company has also offered an attracting discount on these ... of wedding dresses, UWDress.com is good at manufacturing all ... gowns are provided over 20 colors, which have diverse ... famous for high quality. Therefore, its sales increased quickly ...
(Date:11/22/2014)... November 22, 2014 Sandbridge Capital, ... investments in the consumer brand sector, acquired a ... will be used to help fund BackJoy’s global ... rollout, particularly its proprietary apparel and footwear lines. ... BackJoy’s Board of Directors. , BackJoy is a ...
(Date:11/22/2014)... “Greenfield Naturals” was featured on NewsWatch as part ... the latest and coolest technology products available to consumers. ... conducted the product review and shared with viewers how ... , From pollution to hazardous substances in water, harmful ... to remove these chemicals, especially in water. , A ...
(Date:11/22/2014)... 2014 (HealthDay News) -- A clinical trial of hydroxyurea ... halted a year early because the results show it ... disease and reduce the risk of stroke. The ... medical centers in the United States and Canada, was ... and Blood Institute (NHLBI). Researchers compared monthly blood ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2
... , WASHINGTON , Jan. 25 The American ... comprehensive health reform legislation to the president in the coming weeks. ... Executive Director Georges C. Benjamin , MD, FACP, FACEP (E), ... challenging, we cannot allow politics to derail the much needed reform ...
... , PHILADELPHIA , Jan. 25 ... common birth defects in humans, affecting 8 per 1000 ... intervention in early infancy. Increasing numbers of survivors combined ... achievement have led to a growing identification of neurobehavioral ...
... may help prevent future epidemics, , MONDAY, Jan. 25 ... genomes from three successive epidemics of flesh-eating bacteria have ... events that contribute to deadly epidemics of severe infection. ... help prevent major epidemics in the future, the American ...
... for the mind and body, series of studies finds , MONDAY, ... more evidence on the matter, along come four new studies verifying ... plan to survive to a vigorous, hardy and tough-boned old age. ... of the Archives of Internal Medicine . , "I like ...
... Jan. 25 Hylant Group, one of the ... the W Group, a privately owned firm offering employee benefit ... service and greater expertise. The combined organizations will form one ... Cincinnati area.   , The merger between the two ...
... WASHINGTON , Jan. 25 On January ... and Children voted unanimously to add screening for Severe Combined Immune ... to the core panel for universal screening of all newborns in ... affected infants lack T lymphocytes, the white blood cells that help ...
Cached Medicine News:Health News:APHA Urges Congress to Forge Ahead on Health Reform 2Health News:Special Bypass Procedure Used During Infant Heart Surgery Does Not Impair Later Neurological Outcomes in Children 2Health News:Special Bypass Procedure Used During Infant Heart Surgery Does Not Impair Later Neurological Outcomes in Children 3Health News:Scientists Find Way to Track Flesh-Eating Bacteria 2Health News:More Proof Exercise Leads to Healthier Aging 2Health News:More Proof Exercise Leads to Healthier Aging 3Health News:Two of Cincinnati's Leading Employee Benefit Providers Merge to Offer Clients Greater Expertise and Service 2Health News:Immune Deficiency Foundation Praises ACHDNC Recommendation for SCID Screening in Newborns 2Health News:Immune Deficiency Foundation Praises ACHDNC Recommendation for SCID Screening in Newborns 3Health News:Immune Deficiency Foundation Praises ACHDNC Recommendation for SCID Screening in Newborns 4
... Innovators in Anesthesia and Respiratory Products, ... medical devices for Anesthesia and Respiratory professionals. ... products that enhance the clinician's ability to ... attention to the bottom line. , ...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
... the new PRONEB® ULTRA compressor. This high ... while delivering more medication to the patient's ... PLUS® or PARI LC STAR® Reusable Nebulizer, ... for inhalation and retention into the lungs. ...
... use with metered dose inhalers., ,ACE ... from MDI canisters. Its versatile design allows ... circuit, in conjunction with an endotracheal airway ... inhalation. ACE may also be used in ...
Medicine Products: